Concepedia

Ian M. Silverman

IM

30

Publications

2.3K

Citations

21

H-Index

2013

Active since

Affiliations

University of Pennsylvania(Current)

Incyte (United States)

The University of Texas MD Anderson Cancer Center

Massachusetts General Hospital

Harvard University

Ian M. Silverman is an author at University of Pennsylvania specializing in medicine, genetics, and gene expression.

ORCID

Top concepts

Publications per year

2013–2023

30

Publications

30

Loss of NAD Homeostasis Leads to Progressive and Reversible Degeneration of Skeletal Muscle

David W. Frederick, Emanuele Loro, Ling Liu et al. · Cell Metabolism · 2016 · 372 citations · Full text

, , +9

Clinicogenomic Analysis of <i>FGFR2</i> -Rearranged Cholangiocarcinoma Identifies Correlates of Response and Mechanisms of Resistance to Pemigatinib

Ian M. Silverman, Antoine Hollebecque, Luc Friboulet et al. · Cancer Discovery · 2020 · 269 citations · Full text

FIGHT-101, a first-in-human study of potent and selective FGFR 1-3 inhibitor pemigatinib in pan-cancer patients with FGF/FGFR alterations and advanced malignancies

Vivek Subbiah, Nicholas Iannotti, Martin Gutierrez et al. · Annals of Oncology · 2022 · 189 citations · Full text

HAMR: high-throughput annotation of modified ribonucleotides

Paul Ryvkin, Yuk Yee Leung, Ian M. Silverman et al. · RNA · 2013 · 145 citations · Full text

, , +21

Truncated FGFR2 is a clinically actionable oncogene in multiple cancers

Daniel Zingg, Jinhyuk Bhin, Julia Yemelyanenko et al. · Nature · 2022 · 124 citations · Full text

Rows per page

1–5 of 30